122 related articles for article (PubMed ID: 2363304)
1. Protection of mice inoculated with purified pertussis toxin and filamentous haemagglutinin against intracerebral challenge with live Bordetella pertussis.
Gupta RK; Saxena SN; Sharma SB; Ahuja S
Vaccine; 1990 Jun; 8(3):289. PubMed ID: 2363304
[No Abstract] [Full Text] [Related]
2. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
Sato H; Sato Y
Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model.
Watanabe M; Komatsu E; Abe K; Iyama S; Sato T; Nagai M
Vaccine; 2002 Jan; 20(9-10):1429-34. PubMed ID: 11818163
[TBL] [Abstract][Full Text] [Related]
4. Protection against intranasal infection of mice with Bordetella pertussis.
Robinson A; Ashworth LA; Baskerville A; Irons LI
Dev Biol Stand; 1985; 61():165-72. PubMed ID: 2872102
[TBL] [Abstract][Full Text] [Related]
5. Serological correlates in whooping cough.
Granström M; Granström G
Vaccine; 1993; 11(4):445-8. PubMed ID: 8470429
[TBL] [Abstract][Full Text] [Related]
6. Pertussis whole cell vaccine: relation between intracerebral protection in mice and antibody response to pertussis toxin, filamentous hemagglutinin and adenylate cyclase.
Dellepiane NI; Manghi MA; Eriksson PV; di Paola G; Cangelosi A
Zentralbl Bakteriol; 1992 Jun; 277(1):65-73. PubMed ID: 1520970
[TBL] [Abstract][Full Text] [Related]
7. Serum IgG antibody response to pertussis toxin in persons for whom pertussis vaccination failed depends upon the number of antigens in the vaccine.
Cherry JD
Clin Infect Dis; 1999 Mar; 28(3):560-1. PubMed ID: 10194078
[No Abstract] [Full Text] [Related]
8. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
[TBL] [Abstract][Full Text] [Related]
9. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells.
Conway MA; Madrigal-Estebas L; McClean S; Brayden DJ; Mills KH
Vaccine; 2001 Feb; 19(15-16):1940-50. PubMed ID: 11228364
[TBL] [Abstract][Full Text] [Related]
10. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
Cahill ES; O'Hagan DT; Illum L; Redhead K
FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
[TBL] [Abstract][Full Text] [Related]
11. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.
Oda M; Cowell JL; Burstyn DG; Manclark CR
J Infect Dis; 1984 Dec; 150(6):823-33. PubMed ID: 6094673
[TBL] [Abstract][Full Text] [Related]
12. Serospecific protection of mice against intranasal infection with Bordetella pertussis.
Robinson A; Gorringe AR; Funnell SG; Fernandez M
Vaccine; 1989 Aug; 7(4):321-4. PubMed ID: 2573215
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a three-component acellular pertussis vaccine administered at birth.
Belloni C; De Silvestri A; Tinelli C; Avanzini MA; Marconi M; Strano F; Rondini G; Chirico G
Pediatrics; 2003 May; 111(5 Pt 1):1042-5. PubMed ID: 12728086
[TBL] [Abstract][Full Text] [Related]
14. Effects of adsorption of acellular pertussis antigens onto different aluminium salts on the protective activity in an intranasal murine model of Bordetella pertussis infection.
Denoël P; Poolman J; Carletti G; Veitch K
Vaccine; 2002 Jun; 20(19-20):2551-5. PubMed ID: 12057612
[TBL] [Abstract][Full Text] [Related]
15. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
[TBL] [Abstract][Full Text] [Related]
17. Molecular aspects of Bordetella pertussis pathogenesis.
Locht C
Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
[TBL] [Abstract][Full Text] [Related]
18. Effect of heptakis (2,6-0-dimethyl)beta-cyclodextrin on cell growth and the production of pertussis toxin and filamentous hemagglutinin in Bordetella pertussis.
Suzuki Y; Imaizumi A; Ginnaga A; Sato H; Sato Y
Dev Biol Stand; 1985; 61():89-92. PubMed ID: 2872134
[TBL] [Abstract][Full Text] [Related]
19. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin.
Zackrisson G; Taranger J; Trollfors B
J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488
[TBL] [Abstract][Full Text] [Related]
20. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
